| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | 0.35 | 0.1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.083 | 0.1 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.2 | 0.1 |